As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

AstraZeneca and Daiichi Sankyo's anti-HER2 drug Enhertu has been shown to provide a benefit in a phase 3 trial in early-stage ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

The data used to train the AI – including vaccination records, GP visits, hospital admissions, and A&E attendances – is being ...

The aim is to make sure that foreign companies "receive the same level of regulatory oversight and scrutiny as domestic ...

Controversial doctor Vinay Prasad, a public health researcher at UCSF known as a critic of US health policy, has been named ...

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the most recent trends and technologies. One important piece of the puzzle that ...

The most successful pharma sales teams will be those that define and service customers in new ways. Those who are the most responsive and relevant to today's customers and influencers will reap ...

Acadia Pharma's attempts to extend the indications of its Nuplazid drug in the US to include Alzheimer's disease-related psychosis have suffered another major setback. Nuplazid (pimavanserin) is ...

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...

Two years after it was first proposed and a year after it officially launched, the pharma-backed AMR Action Fund has made its first investments in companies trying to tackle the pressing problem ...